IMMUNITYBIO INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$8.29
-5.15%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-10.7%
3 months
+15.9%
6 months
+16.6%
1 year
+251.3%
Year to date
+318.7%
52-week range
$1.98 – $11.55
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$8.79B
P/E
-8.9
P/B
-8.4
P/S
53
Revenue
$165.79M
Net income
-$992.36M
Diluted EPS
-0.97
Gross margin
99.30%
Net margin
-598.60%
Return on equity
134.90%
Total debt
$1.23B
Cash
$75.67M
Free cash flow
-$288.51M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $51.24M | -$230.38M | 99.40% | -449.60% | -$70.03M |
| Mar 31, 2026 | $44.21M | -$632.78M | 99.50% | -1431.40% | -$77.15M |
| Dec 31, 2025 | $38.29M | -$61.94M | 99.00% | -161.80% | -$71.65M |
| Sep 30, 2025 | $32.06M | -$67.25M | 99.40% | -209.80% | -$69.68M |
| Jun 30, 2025 | $26.43M | -$92.56M | 99.50% | -350.30% | -$80.83M |
| Mar 31, 2025 | $16.52M | -$129.65M | 99.60% | -784.90% | -$87.03M |
| Dec 31, 2024 | $7.55M | -$59.16M | 100.00% | -783.40% | -$87.26M |
| Sep 30, 2024 | $6.11M | -$85.73M | 100.00% | -1404.00% | -$101.56M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent IBRX news
All market newsNo ticker-linked stories are in the current archive.